Note D: Financial non-current assets
|
Subsidiaries |
|
|
|||
|---|---|---|---|---|---|---|
In € millions |
Share in capital |
Loans* |
Other non-current assets |
Total |
||
|
||||||
Balance at December 31, 2017 |
10,169 |
1,228 |
99 |
11,496 |
||
Impact adoption IFRS 9 |
(3) |
– |
– |
(3) |
||
Impact adoption IFRS 15 |
(48) |
– |
– |
(48) |
||
Impact application IAS 29 |
23 |
– |
– |
23 |
||
Balance at January 1, 2018 |
10,141 |
1,228 |
99 |
11,468 |
||
Acquisitions/capital contributions |
– |
– |
11 |
11 |
||
Divestments/capital repayments |
(1,177) |
– |
(4) |
(1,181) |
||
Net income from subsidiaries |
1,599 |
– |
– |
1,599 |
||
Equity-settled transactions |
26 |
– |
– |
26 |
||
Transactions with non-controlling interests |
(223) |
– |
– |
(223) |
||
Loans granted |
– |
1,003 |
– |
1,003 |
||
Repayment of loans |
– |
(279) |
– |
(279) |
||
Changes in exchange rates |
(84) |
(3) |
– |
(87) |
||
Dividends received |
(1,070) |
– |
– |
(1,070) |
||
Other changes |
34 |
|
(2) |
32 |
||
Balance at December 31, 2018 |
9,246 |
1,949 |
104 |
11,299 |
||
Investments/acquisitions/capital contributions |
179 |
– |
34 |
213 |
||
Divestments/capital repayments |
(760) |
– |
– |
(760) |
||
Net income from subsidiaries |
564 |
– |
– |
564 |
||
Equity-settled transactions |
14 |
– |
– |
14 |
||
Loans granted |
– |
1,079 |
– |
1,079 |
||
Repayment of loans |
– |
(779) |
– |
(779) |
||
Changes in exchange rates |
139 |
(4) |
– |
135 |
||
Post-retirement benefits |
(223) |
– |
– |
(223) |
||
Other changes |
– |
– |
(2) |
(2) |
||
Balance at December 31, 2019 |
9,159 |
2,245 |
136 |
11,540 |
||
Due to an intra-group funding restructuring, several intercompany loans were transferred in 2019 and will be transferred in 2020 from certain foreign subsidiaries to Akzo Nobel N.V..